Skip to product information
1 of 1

IL-11 Protein, Rat

IL-11 Protein, Rat

Catalog Number: UA040359 Reactivity: Rat Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $220.00 USD
Regular price Sale price $220.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Rat
Synonyms Interleukin-11; IL-11;
Accession Q99MF5
Amino Acid Sequence

Pro22-Leu199

Expression System E.coli
Molecular Weight

21 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized Powder
Storage Buffer 20mM Tris, 300mM NaCl, pH8.0
Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Cancer Cell. 2013 Aug 12;24(2):257-71.

Background

Interleukin-11 (IL-11) is a cytokine belonging to the IL-6 family that plays a crucial role in various physiological processes, including hematopoiesis, bone metabolism, and gastrointestinal mucosal protection. In rats, IL-11 is primarily produced by stromal cells in the bone marrow and other cell types, such as fibroblasts and endothelial cells. IL-11 exerts its biological effects by binding to the IL-11 receptor complex, which consists of IL-11Rα and gp130 subunits, leading to the activation of signaling pathways such as the JAK-STAT pathway. IL-11 has been shown to promote the growth and differentiation of hematopoietic progenitor cells, stimulate platelet production, and enhance bone formation. Additionally, IL-11 has anti-inflammatory properties and is being investigated for its potential therapeutic applications in conditions such as osteoporosis and inflammatory bowel disease.

Picture

Bioactivity

Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. The EC50 for this effect is less than 5ng/ml.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

>95% as determined by RP-HPLC.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)